Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 1,671: | Line 1,671: | ||
| | | | ||
|- | |- | ||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| | |'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Lymphomatoid Papulosis||Disease|| | | Lymphomatoid Papulosis||Disease||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Primary Cutaneous | | Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD | ||
| | | | ||
| | | | ||
| Line 1,695: | Line 1,695: | ||
| | | | ||
|- | |- | ||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| | |'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Primary Cutaneous | | Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Primary Cutaneous | | Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Primary Cutaneous | | Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Primary Cutaneous | | Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||SP | | ||SP | ||
| | | | ||